Sirolimus combined with oseltamivir and corticosteroid treatment for a puerpera with severe pneumonia caused by 2009 pandemic H1N1: A case report

被引:0
|
作者
Suo Lijun
Yu Xiaofeng
Hu Yongfeng
Cao Hongyun
Zou Xiaohui
Wang Peiquan
Xu Tao
Zhou Xiangzhi
Wu Yexin
Ren Lili
Liu Bo
Cao Bin
机构
[1] Beijing 100029
[2] Beijing 100730
[3] Center for Respiratory Diseases
[4] China
[5] China-Japan Friendship Hospital
[6] Chinese Academy of Medical Sciences &amp
[7] Department of Critical Care Medicine
[8] Department of Pulmonary and Critical Care Medicine
[9] Institute of Pathogen Biology
[10] National Health Commission Key Laboratory of Systems Biology of Pathogens and Christophe Mérieux Laboratory
[11] Peking Union Medical College
[12] Tsinghua University-Peking University Joint Center for Life Sciences
[13] Zibo 255400
[14] Zibo City Engineering Technology Research Center of Etiology Molecular Diagnosis
[15] Zibo City Key Laboratory of Respiratory Infection and Clinical Microbiology &amp
[16] Zibo Municipal Hospital
关键词
Sirolimus; Oseltamivir; Corticosteroid; Puerpera; Pneumonia; H1N1;
D O I
暂无
中图分类号
R563.1 [肺炎];
学科分类号
1002 ; 100201 ;
摘要
Severe pneumonia in patients infected with the 2009 pandemic H1N1 (pH1N1) virus was partially attributed to excessive immune response. Anti-virus treatment for these patients was insufficient. Here we reported the therapy effect of sirolimus, an immunosuppressor, combined with oseltamivir and corticosteroid for a puerpera with severe pneumonia caused by pH1N1 virus. This patient has infected with the pH1N1 virus in late pregnancy, and antiviral therapy was not implemented timely. She developed severe pneumonia and ARDS rapidly and need receive a cesarean section on the 39th week after pregnancy. After giving birth to a healthy baby, she received a combination of oseltamivir, sirolimus and corticosteroid, and improved in the following days. Moreover, the cytokines in serum and viral loads in BALF decreased significantly. She recovered without infectious symptoms and was discharged. Sirolimus combined with oseltamivir and corticosteroid is likely responsible for lowering the viral loads, reducing the patient’’s cytokine level, and further improving her clinical outcomes. It provides evidence that adjuvant treatment was beneficial to patients with severe pneumonia induced by the pH1N1 virus.
引用
收藏
页码:343 / 350
页数:8
相关论文
共 50 条
  • [21] Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus
    Leung, Y. H.
    Lim, W. L.
    Wong, M. H.
    Chuang, S. K.
    [J]. EPIDEMIOLOGY AND INFECTION, 2012, 140 (05): : 814 - 817
  • [22] Parenteral Peramivir Treatment for Oseltamivir-Resistant 2009 Pandemic Influenza A H1N1 Viruses
    Abed, Yacine
    Boivin, Guy
    Yoshida, Ryu
    Kodama, Makoto
    Hernandez, Jaime E.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2011, 204 (10): : 1641 - 1642
  • [23] Development of Oseltamivir Resistance During Oseltamivir Therapy in a Child With Severe 2009 H1N1 Influenza
    Glikman, Daniel
    Zonis, Zeev
    Hindyieh, Musa
    Ram, Daniela
    Mandelboim, Michal
    Mendelson, Ella
    Engelhard, Dan
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (04) : 385 - 386
  • [24] Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009
    Edward Goldstein
    Benjamin J Cowling
    Justin J O'Hagan
    Leon Danon
    Vicky J Fang
    Angela Hagy
    Joel C Miller
    David Reshef
    James Robins
    Paul Biedrzycki
    Marc Lipsitch
    [J]. BMC Infectious Diseases, 10
  • [25] OUTCOMES OF SEVERE PANDEMIC INFLUENZA A/H1N1/2009
    Klimova, E. A.
    Yushchuk, N. D.
    Karetkina, G. N.
    Boitsov, P. V.
    Serobyan, A. G.
    Kalli, E. I.
    Malyshev, N. A.
    Golokhvastova, N. O.
    Esaulova, M. R.
    Karchevskaya, N. A.
    Avdeyev, S. N.
    [J]. TERAPEVTICHESKII ARKHIV, 2010, 82 (11): : 15 - 18
  • [26] Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections
    Escuret, Vanessa
    Cornu, Catherine
    Boutitie, Florent
    Enouf, Vincent
    Mosnier, Anne
    Bouscambert-Duchamp, Maude
    Gaillard, Segolene
    Duval, Xavier
    Blanchon, Thierry
    Leport, Catherine
    Gueyffier, Francois
    Van der Werf, Sylvie
    Lina, Bruno
    [J]. ANTIVIRAL RESEARCH, 2012, 96 (02) : 130 - 137
  • [27] Treatment with oseltamivir and prone positioning for a 9-year-old boy with ARDS caused by pandemic H1N1 2009 influenza
    Suyama, Kazuhide
    Kawasaki, Yukihiko
    Suzuki, Yuichi
    Ishii, Kiyoko
    Sakai, Nobuko
    Sato, Masatoki
    Hashimoto, Kohichi
    Hosoya, Mitsuaki
    [J]. PEDIATRICS INTERNATIONAL, 2013, 55 (03) : e77 - e80
  • [28] Compelling Results of Adjuvant Therapy With Sirolimus for Severe H1N1 Pneumonia
    Chuang, Yu-Chung
    Ruan, Sheng-Yuan
    Huang, Chun-Ta
    [J]. CRITICAL CARE MEDICINE, 2014, 42 (10) : E687 - E688
  • [29] A Case of Acute Myocarditis Caused by Pandemic (H1N1) 2009 Influenza Virus
    Pavlidis, Antonios N.
    Giannakopoulos, Antreas K.
    Danias, Peter G.
    Manolis, Athanasios J.
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2010, 109 (11) : 857 - 858
  • [30] Characterization of Oseltamivir-Resistant 2009 H1N1 Pandemic Influenza A Viruses
    Kiso, Maki
    Shinya, Kyoko
    Shimojima, Masayuki
    Takano, Ryo
    Takahashi, Kei
    Katsura, Hiroaki
    Kakugawa, Satoshi
    Mai Thi Quynh Le
    Yamashita, Makoto
    Furuta, Yousuke
    Ozawa, Makoto
    Kawaoka, Yoshihiro
    [J]. PLOS PATHOGENS, 2010, 6 (08) : 97 - 98